Medication Reconciliation in an Emergency Department: How to Prioritize Patients ?
NCT03955965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-05-20
Summary
Medication reconciliation has proven its efficiency in improving patients' care, especially for emergency patients.
This study aimed to identify risk factors of unintended medication discrepancies (UMD) in an emergency department. Secondary objectives were to identify the number and type of UMD, correction rate of UMD and the impact of emergency department organisation on UMD.
Conditions
- Emergency Service, Hospital
- Medication Reconciliation
Interventions
- OTHER
-
Medication reconciliation
No intervention was performed other than collecting data on patients' medical files
Sponsors & Collaborators
-
Fondation Hôpital Saint-Joseph
lead OTHER
Principal Investigators
-
Jennifer Corny, PharmD · Pharmacy Department
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2018-05-01
- Completion
- 2018-11-15
Countries
- France
Study Locations
More Related Trials
-
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
NCT02557984 ·Status: COMPLETED ·Phase: NA
-
Low Dose Ketamine Intra Nasal Traumatology
NCT03233035 ·Status: COMPLETED ·Phase: PHASE2
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
NCT04266288 ·Status: COMPLETED ·Phase: PHASE4
-
Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users
NCT06446349 ·Status: RECRUITING ·Phase: NA
-
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
NCT05696691 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Endogenous Opioid Modulation by Ketamine
NCT03051945 ·Status: WITHDRAWN ·Phase: PHASE3
-
Dose-dependent Effects of Oxytocin on the Amygdala and Reward System
NCT03846739 ·Status: COMPLETED ·Phase: PHASE1
-
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192 ·Status: UNKNOWN ·Phase: NA
-
Quantitative Xylazine Measurement in ED
NCT06949605 ·Status: COMPLETED
-
Epidemiology of Acute Self-poisoning in Emergency Services in France
NCT02518386 ·Status: COMPLETED
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
NCT07023419 ·Status: RECRUITING
-
The Effect of D-cycloserine on Emotional Processing
NCT03961464 ·Status: COMPLETED ·Phase: NA
-
Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization
NCT06931197 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Human Stress Response in a Simulated ED Setting
NCT04317482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Oxytocin and the Processing of Social Stress-Associated Chemosignals
NCT03265899 ·Status: COMPLETED ·Phase: PHASE1
-
A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects
NCT06303648 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
NCT04113343 ·Status: COMPLETED ·Phase: PHASE1
-
Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT05115981 ·Status: COMPLETED
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
NCT04173546 ·Status: COMPLETED
-
Dose-response of Cannabis and Driving
NCT03656029 ·Status: COMPLETED ·Phase: PHASE2
-
Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.
NCT02668926 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Medication on Functional Connectivity
NCT03612713 ·Status: COMPLETED ·Phase: EARLY_PHASE1